EVOK logo
EVOK NASDAQ US

Evoke Pharma, Inc. - Common Stock

Healthcare · Pharmaceuticals Website · IPO Sep 2013
$11.00
+0.0 (+0.0%)
4
Quality Score
fail
Mkt Cap
$18.9M
ROE
-101.4%
Margin
-36.2%
D/E
148.71
Beta
-0.11
52W
$2–$11

Wall Street Consensus

6 analysts · Apr 2026
0
Strong Buy
0
Buy
3
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating

Price Chart

Similar Stocks

VYNE
Vyne Therapeutics Inc
$19.3M
CTXR
Citius Pharmaceuticals Inc
$16.1M
LPCN
Lipocine Inc
$44.6M
HIND
Vyome Holdings Inc
$19.4M
CURX
Curanex Pharmaceuticals Inc
$9.4M
TRAW
Traws Pharma Inc
$9.0M
JUNS
Jupiter Neurosciences Inc
$35.1M

Earnings

Beat rate: 50.0%
Next Report May 11, 2026
Quarter EPS Est EPS Act Surprise
Mar 2026 — — —
Sep 2025 $-0.46 $-0.45 +$0.01
Jun 2025 $-0.31 $-0.62 $-0.31
Mar 2025 $-0.34 $-0.51 $-0.17

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -99.5% -101.9% -99.5% -99.5% -101.4% -101.4%
P/E (TTM) — — — — — —
Net Margin -41.9% -43.8% -42.1% -42.1% -36.2% -36.2%
Gross Margin 95.5% 97.4% 96.6% 96.6% 97.0% 97.0%
D/E Ratio 114.30 85.60 114.30 114.30 148.71 148.71
Current Ratio 1.37 1.55 1.37 1.37 1.27 1.27

Key Ratios

ROA (TTM)
-31.9%
P/S (TTM)
1.31
P/B
0.9
EPS (TTM)
$-1.92
CF/Share
$-2.28
Rev Growth 3Y
+85.0%
52W High
$11.00
52W Low
$1.94
$1.94 52-Week Range $11.00

How does EVOK compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

EVOK AARD ACB ACRS ADIL

EVOK valuation vs Pharmaceuticals peers

P/E ratio
—
▼ 0% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
1.3
▼ 73% below peers (5.0)
vs Peers
vs Industry
Undervalued
P/B ratio
0.9
▼ 56% below peers (2.1)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (2.0%)
vs Peers
vs Industry
Low yield

EVOK profitability vs Pharmaceuticals peers

ROE
-101.4%
▼ 87% below peers (-54.3%)
vs Peers
vs Industry
Weak
Net margin
-36.2%
▲ 24% above peers (-47.4%)
vs Peers
vs Industry
Weak
Gross margin
97.0%
▲ 42% above peers (68.3%)
vs Peers
vs Industry
Below avg
ROA
-31.9%
▲ 15% above peers (-37.4%)
vs Peers
vs Industry
In line

EVOK financial health vs Pharmaceuticals peers

D/E ratio
148.7
▲ 9556% above peers (1.5)
vs Peers
vs Industry
High debt
Current ratio
1.3
▼ 62% below peers (3.4)
vs Peers
vs Industry
Low liquidity
Beta
-0.1
▼ 112% below peers (0.9)
vs Peers
vs Industry
More volatile

EVOK fundamentals radar

EVOK Peer median Industry

EVOK profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

EVOK vs peers: key metrics

Latest News

No related news yet